Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | natamycin | 5284447 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | natamycin | 5284447 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | natamycin | 5284447 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | saquinavir | 5284550 | drug-path |
| Insulin signaling pathway | R-HSA-74752 | map04910 | saquinavir | 5284550 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | saquinavir | 5284550 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | saquinavir | 5284550 | drug-path |
| Gap junction | R-HSA-190861 | map04540 | saquinavir | 5284550 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | saquinavir | 5284550 | drug-path |
| SNARE interactions in vesicular transport | R-HSA-428625 | map04130 | saquinavir | 5284550 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | saquinavir | 5284550 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | saquinavir | 5284550 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | saquinavir | 5284550 | drug-path |
| Chemokine signaling pathway | R-HSA-168638 | map04062 | saquinavir | 5284550 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | saquinavir | 5284550 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | saquinavir | 5284550 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | quercetin | 5281004 | drug-path |
| Ubiquitin mediated proteolysis | R-HSA-983153 | map04120 | quercetin | 5281004 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | quercetin | 5281004 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | quercetin | 5281004 | drug-path |